Home › Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific
 

Keywords :   


Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific

2014-05-13 08:15:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it signed an agreement for Santen Pharmaceutical Co., Ltd. Language: English Contact: MerckMedia:Caroline Lappetito, 267-218-1584orMamoru Ohara, 81-3-6272-1001orInvestor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: products key sale japan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
29.09Rates low for too long, says ex-Bank of England boss
29.09Weekly Recap: Freudenberg Expands Coated Textiles Business, Trade Associations to Explore Alliance
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Forecast Advisory Number 9
29.09Summary for Tropical Storm Joyce (AT1/AL112024)
29.09Hurricane Isaac Graphics
More »